Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -8,626 | -17,450 |
| Depreciation Amortization | 322 | 800 |
| Income taxes - deferred | -946 | N/A |
| Accounts payable and accrued liabilities | 3,044 | N/A |
| Other Working Capital | 5,222 | 58,560 |
| Other Operating Activity | -2,504 | -500 |
| Operating Cash Flow | $-3,488 | $41,410 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,095 | -830 |
| Sale Of Investment | 14,591 | N/A |
| Other Investing Activity | 0 | -69,130 |
| Investing Cash Flow | $13,496 | $-69,960 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 25,940 |
| Financing Cash Flow | $N/A | $25,940 |
| Beginning Cash Position | 11,080 | 12,600 |
| End Cash Position | 21,088 | 9,990 |
| Net Cash Flow | $10,008 | $-2,610 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,488 | 41,410 |
| Capital Expenditure | -1,095 | N/A |
| Free Cash Flow | -4,583 | 41,410 |